New Zealand's Me Today FY26 swings to profit on King Honey deconsolidation

Me Today

26/08/2026 21:44

Overview
New Zealand health supplements maker's FY26 gross revenue rose 36% to NZ$7.96 mln, topping guidance
EBITDA loss narrowed to NZ$1.23 mln, ahead of guidance for a loss of less than NZ$1.6 mln
Company secured minimum NZ$1.59 mln new capital via warrant commitments from largest shareholders

Outlook
Me Today secures at least NZ$1.59 mln from Series 1 warrant commitments in October 2026
New product pipeline plans 20 launches across the remainder of calendar 2026
Me Today expects Malaysia to follow Singapore in its South East Asia rollout in calendar 2027

Result Drivers
KING HONEY DECONSOLIDATION – Net profit of NZ$2.66 mln reflected a NZ$4.1 mln gain from derecognising King Honey's net liabilities after its receivership
CHINA LICENSING - Licence-fee revenue rose to NZ$1.11 mln from NZ$445,000, reflecting a shift from a fixed-fee to revenue-based structure
PRODUCT PORTFOLIO EXPANSION – The company launched 15 products during FY26, expanding formats across liquids, capsules, resin and powdered supplementstribution agreement in SE Asia, with initial sales in Singapore and plans for expansion

Company press release: ID:nNZS8qya

Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
FY Revenue
 
NZ$6.53 mln
 
FY Gross Revenue
 
NZ$7.96 mln
 
FY NPAT
 
NZ$2.66 mln
 
FY EBITDA
 
-NZ$1.23 mln
 

Reuters Recommended Reads
Aug 25 - China's H&H International half-year revenue rises, profit surges on margin expansion 
Aug 25 - Sweden's Zinzino Q2 revenue rises 18%, profitability improves
Aug 26 - Singapore's Alliance Healthcare FY revenue rises 13%

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)